Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure

AIM: The optimal strategy for diabetes control in patients with heart failure (HF) following myocardial infarction (MI) remains unknown. Metformin, a guideline‐recommended therapy for patients with chronic HF and type 2 diabetes mellitus (T2DM), is associated with reduced mortality and HF hospitaliz...

Descripción completa

Detalles Bibliográficos
Autores principales: Godec, Thomas R., Bromage, Daniel I., Pujades‐Rodriguez, Mar, Cannatà, Antonio, Gonzalez‐Izquierdo, Arturo, Denaxas, Spiros, Hemingway, Harry, Shah, Ajay M., Yellon, Derek M., McDonagh, Theresa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065866/
https://www.ncbi.nlm.nih.gov/pubmed/35322592
http://dx.doi.org/10.1002/ehf2.13910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065866/
https://www.ncbi.nlm.nih.gov/pubmed/35322592
http://dx.doi.org/10.1002/ehf2.13910

Ejemplares similares